Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
By A. Everard, C. Belzer, L. Geurts, J. P. Ouwerkerk, Céline Druart, L. Bindels, Y. Guiot, M. Derrien, G. Muccioli, N. Delzenne and 2 more. Proceedings of the National Academy of Sciences of the United States of America, 2013
4,154 citations recorded by the source corpus.
Obesity and type 2 diabetes are characterized by altered gut microbiota, inflammation, and gut barrier disruption. Microbial composition and the mechanisms of interaction with the host that affect gut barrier function during obesity and type 2 diabetes have not been elucidated. We recently isolated Akkermansia muciniphila, which is a mucin-degrading bacterium that resides in the mucus layer. The presence of this bacterium inversely correlates with body weight in rodents and humans. However, the precise physiological roles played by this bacterium during obesity and metabolic disorders are unknown. This study demonstrated that the abundance of A. muciniphila decreased in obese and type 2 diabetic mice. We also observed that prebiotic feeding normalized A. muciniphila abundance, which correlated with an improved metabolic profile. In addition, we demonstrated that A. muciniphila treatment reversed high-fat diet-induced metabolic disorders, including fat-mass gain, metabolic endotoxemia, adipose tissue inflammation, and insulin resistance. A. muciniphila administration increased the intestinal levels of endocannabinoids that control inflammation, the gut barrier, and gut peptide secretion. Finally, we demonstrated that all these effects required viable A. muciniphila because treatment with heat-killed cells did not improve the metabolic profile or the mucus layer thickness. In summary, this study provides substantial insight into the intricate mechanisms of bacterial (i.e., A. muciniphila) regulation of the cross-talk between the host and gut microbiota. These results also provide a rationale for the development of a treatment that uses this human mucus colonizer for the prevention or treatment of obesity and its associated metabolic disorders.
Subfields: Biological Psychiatry, Food Science, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/0da45a2833f245a03e68a3115269fd1cde81675f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biological Psychiatry
In Food Science
- W. D. de Vos
- Patrice D Cani
- C. Belzer
- M. Rajilić-Stojanović
- M. Derrien
- Eric A. Franzosa
- Lei Cheng
- Faming Zhang
In Molecular Biology
- J. Cryan
- Ted G. Dinan
- Patrice D Cani
- W. D. de Vos
- G. Clarke
- Curtis Huttenhower
- C. Stanton
- P. Kennedy
Citations in the corpus
- Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice. (2017, positive): “has received a lot of attention for its beneficial role in the host-like protection from diet-induced obesity, insulin resistance, intestinal inflammation (44–46), and gut barrier impairment (47), and it was also found to thicken the mucin layer (48).”
- The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients? (2020, background): “muciniphila (Verrucomicrobia phylum), a mucin degrading bacterium contributing to the stabilization of the gut barrier function, the secretion of antibacterial peptides, and control of inflammation [48,49].”
- Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016, background): “2434 The gut microbiota, a complex community of >100 trillion microbes, plays an important physiological role in modulating host nutrition, metabolism, and immunity.(1,2)”
- The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota (2017, background): “muciniphila on intestinal barrier function and demonstrated that its administration protects against diet-induced obesity (447).”
- Bifidobacteria or fiber protect against diet-induced microbiota-mediated colonic mucus deterioration (2017, methodology): “Previous studies (Desai et al., 2016; Earle et al., 2015; Everard et al., 2013) that evaluated mucus thickness in fixed tissue sections described thinner colonic mucus in mice that were fed low-fiber diets for short periods of time (10 – 40 days).”